Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study.
Carlo Bruno GiordaEmanuela OrsiSalvatore De CosmoAntonio Carlo BossiCatia GuerzoniStefania CerconeBarbara GilioFranco CavalotPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)
The results of this study provide evidence of a high rate of inappropriate SU prescription risk among patients with T2DM, especially among those with overweight/obesity, older age, history of cardiovascular disease, and hypoglycemia.